1147014-68-3 Usage
General Description
The chemical 7H-Pyrrolo[2,3-d]pyriMidine, 4-[2-(triMethylsilyl)ethynyl]- is a pyrrolopyrimidine derivative containing a triMethylsilyl ethynyl group. It is commonly used in medicinal chemistry and drug discovery as a building block for the synthesis of various biologically active compounds. The triMethylsilyl group can enhance the stability and reactivity of the molecule, making it a valuable intermediate in the preparation of pharmaceuticals and agrochemicals. 7H-Pyrrolo[2,3-d]pyriMidine, 4-[2-(triMethylsilyl)ethynyl]- has potential applications in the development of new drugs and agrochemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 1147014-68-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,7,0,1 and 4 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1147014-68:
(9*1)+(8*1)+(7*4)+(6*7)+(5*0)+(4*1)+(3*4)+(2*6)+(1*8)=123
123 % 10 = 3
So 1147014-68-3 is a valid CAS Registry Number.
1147014-68-3Relevant articles and documents
Solution-phase parallel synthesis of ruxolitinib-derived Janus kinase inhibitors via copper-catalyzed azide-alkyne cycloaddition
Gehringer, Matthias,Forster, Michael,Laufer, Stefan A.
supporting information, p. 5 - 10 (2015/01/30)
A solution-phase parallel synthesis of triazole-derived ruxolitinib analogues was developed in the current study. The method employs copper-catalyzed azide-alkyne cycloaddition to build up the central triazole template. Product isolation by precipitation
PYRROLOPYRIMIDINE ALKYNYL COMPOUNDS AND METHODS OF MAKING AND USING SAME
-
Page/Page column 53, (2009/05/30)
Provided herein are pyrrolopyrimide alkynyl compounds, and methods of making and using the same. Such compounds may be used in inflammatory or myeloproliferative disorders. The disclosure also provides for treating cancer.
